After decades of research and development, gene therapy is becoming a clinical reality in the US. With the first gene therapies already approved and many more in the pipeline, healthcare providers may soon gain the ability to treat more rare conditions.
To address this exciting topic, NORD is hosting a 5-part series on gene therapy. In part-2 of the series, The Science Behind Gene Therapy, we will explore how gene therapies are developed, the ways in which evidence-based science guides manufacturers of gene therapies, how vectors deliver gene therapies to the cells and what happens inside the body after gene therapy is delivered.We will cover these topics and more in this free webinar on September 25.
This webinar is perfect for patients, caregivers, advocates, students and the public.
Sven Kili, MD, Principal at Sven Kili Consulting Ltd., provides strategic consulting services to regenerative medicine companies.
The Science Behind Gene Therapy is the second webinar in an exciting five-part series on gene therapy from NORD in collaboration with the American Society for Gene and Cell Therapy (ASGCT.) Join us for upcoming topics in the series include the following.
NORD thanks AVROBIO, Amicus, Bluebird Bio and Sarepta for their support of this educational resource.